{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:07:02Z","timestamp":1790564822800,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.plefa.2020.102142","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T06:22:54Z","timestamp":1590819774000},"page":"102142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Caprylic (Octanoic) Acid as a Potential Fatty Acid Chemotherapeutic for Glioblastoma"],"prefix":"10.1016","volume":"159","author":[{"given":"Meric A","family":"Altinoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Ozpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2020.102142_bib0001","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10528-016-9754-9","article-title":"A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme","volume":"54","author":"Elmaci","year":"2016","journal-title":"Biochem Genet"},{"key":"10.1016\/j.plefa.2020.102142_bib0002","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12094-017-1613-6","article-title":"Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential","volume":"19","author":"Altinoz","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.plefa.2020.102142_bib0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnut.2018.00091","article-title":"Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma","volume":"5","author":"Augur","year":"2018","journal-title":"Front Nutr"},{"key":"10.1016\/j.plefa.2020.102142_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s12986-017-0178-2","article-title":"Press-pulse: a novel therapeutic strategy for the metabolic management of cancer","volume":"14","author":"Seyfried","year":"2017","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.plefa.2020.102142_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759091418818261","article-title":"Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis","volume":"10","author":"Chinopoulos","year":"2018","journal-title":"ASN Neuro"},{"key":"10.1016\/j.plefa.2020.102142_bib0006","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/j.plefa.2020.102142_bib0007","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s11064-019-02795-4","article-title":"Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?","volume":"44","author":"Seyfried","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.plefa.2020.102142_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnut.2020.00021","article-title":"Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer","volume":"7","author":"Seyfried","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.plefa.2020.102142_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.critrevonc.2017.02.016","article-title":"Role of ketogenic metabolic therapy in malignant glioma: A systematic review","volume":"112","author":"Winter","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.plefa.2020.102142_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbabio.2010.08.009","article-title":"Metabolic management of brain cancer","volume":"10807","author":"Seyfried","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.plefa.2020.102142_bib0011","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eplepsyres.2011.06.017","article-title":"Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?","volume":"100","author":"Seyfried","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.plefa.2020.102142_bib0012","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.canlet.2014.07.015","article-title":"Metabolic therapy: a new paradigm for managing malignant brain cancer","volume":"356","author":"Seyfried","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.plefa.2020.102142_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049191","article-title":"Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.plefa.2020.102142_bib0014","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.fertnstert.2013.03.034","article-title":"Variability in protein quality used for embryo culture: embryotoxicity of the stabilizer octanoic acid","volume":"100","author":"Leonard","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.plefa.2020.102142_bib0015","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3390\/ijms16035014","article-title":"Anticarcinogenic properties of medium chain fatty acids on human colorectal, skin and breast cancer cells in vitro","volume":"16","author":"Narayanan","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.plefa.2020.102142_bib0016","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/clinchem\/28.4.642","article-title":"Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium-chain triglyceride diet","volume":"28","author":"Haidukewych","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.plefa.2020.102142_bib0017","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1432-1033.1992.tb17288.x","article-title":"Evidence for an impaired long-chain fatty acid oxidation and ketogenesis in Fao hepatoma cells","volume":"209","author":"Prip-Buus","year":"1992","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.plefa.2020.102142_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0278-6915(99)00106-4","article-title":"Review of the toxicologic properties of medium-chain triglycerides","volume":"38","author":"Traul","year":"2000","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.plefa.2020.102142_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(17)30408-8","article-title":"Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders","volume":"17","author":"Augustin","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.plefa.2020.102142_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2015.08.002","article-title":"Revisiting the metabolism and physiological functions of caprylic acid (C8:0) with special focus on ghrelin octanoylation","volume":"120","author":"Lemari\u00e9","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.plefa.2020.102142_bib0021","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nut.2012.09.009","article-title":"Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism","volume":"29","author":"Courchesne-Loyer","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.plefa.2020.102142_bib0022","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pnpbp.2014.10.013","article-title":"Acute anticonvulsant effects of capric acid in seizure tests in mice","volume":"57","author":"Wla\u017a","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.plefa.2020.102142_bib0023","first-page":"149","article-title":"Ketoacids? Good medicine?","volume":"114","author":"Cahill Jr","year":"2003","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"10.1016\/j.plefa.2020.102142_bib0024","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1301\/nr.2003.oct.327-341","article-title":"Ketones: metabolism's ugly duckling","volume":"61","author":"VanItallie","year":"2003","journal-title":"Nutr Rev."},{"key":"10.1016\/j.plefa.2020.102142_bib0025","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI107095","article-title":"Resistance to symptomatic insulin reactions after fasting","volume":"51","author":"Drenick","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plefa.2020.102142_bib0026","doi-asserted-by":"crossref","DOI":"10.3945\/cdn.116.000257","article-title":"Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides: An Acute Crossover Study in Healthy Adults","volume":"1","author":"Vandenberghe","year":"2017","journal-title":"Curr Dev Nutr"},{"key":"10.1016\/j.plefa.2020.102142_bib0027","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brainres.2018.05.049","article-title":"Ketogenic diets as a homeostatic link","volume":"1703","author":"Masino","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/j.plefa.2020.102142_bib0028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open."},{"key":"10.1016\/j.plefa.2020.102142_bib0029","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/adc.61.12.1173","article-title":"Role of octanoic and decanoic acids in the control of seizures","volume":"61","author":"Sills","year":"1986","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.plefa.2020.102142_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12986-015-0009-2","article-title":"The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer","volume":"12","author":"Meidenbauer","year":"2015","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.plefa.2020.102142_bib0031","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1096\/fj.201500182","article-title":"Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems","volume":"30","author":"Thevenet","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.plefa.2020.102142_bib0032","first-page":"498","article-title":"Octanoate affects 2,4-dinitrophenol uncoupling in intact isolated rat hepatocytes","volume":"231","author":"Sibille","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.plefa.2020.102142_bib0033","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/0271678X16642448","article-title":"Inhibition of \u03b2-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration","volume":"37","author":"Sch\u00f6nfeld","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.plefa.2020.102142_bib0034","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1074\/jbc.R800068200","article-title":"Mitochondrial fatty acid synthesis type II: more than just fatty acids","volume":"284","author":"Hiltunen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plefa.2020.102142_bib0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/mmi.12402","article-title":"Defects in mitochondrial fatty acid synthesis result in failure of multiple aspects of mitochondrial biogenesis in Saccharomyces cerevisiae","volume":"90","author":"Kursu","year":"2013","journal-title":"Mol Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.plefa.2020.102142_bib0036","article-title":"Rescue of Abeta(1-42)-induced memory impairment in day-old chick by facilitation of astrocytic oxidative metabolism: implications for Alzheimer's disease","volume":"109","author":"Gibbs","year":"2009","journal-title":"J Neurochem."},{"key":"10.1016\/j.plefa.2020.102142_bib0037","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2147\/NDT.S49895","article-title":"Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease","volume":"9","author":"Maynard","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.plefa.2020.102142_bib0039","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.pharep.2018.04.008","article-title":"Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease","volume":"70","author":"Joniec-Maciejak","year":"2018","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.plefa.2020.102142_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/0148607113489833","article-title":"Impact of short- and medium-chain fatty acids on mitochondrial function in severe inflammation","volume":"38","author":"Hecker","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.plefa.2020.102142_bib0041","first-page":"639","article-title":"The oxidation of octanoate by liver homogenates from leucemic mice","volume":"9","author":"Vestling","year":"1949","journal-title":"Cancer Res"},{"key":"10.1016\/j.plefa.2020.102142_bib0042","first-page":"509","article-title":"The oxidative metabolic pattern of mouse hepatoma C954 as studied with C14-labeled acetates, propionate, octanoate, and glucose","volume":"16","author":"Brown","year":"1956","journal-title":"Cancer Res"},{"key":"10.1016\/j.plefa.2020.102142_bib0043","first-page":"37","article-title":"Inhibition of glycolytic enzymes of normal and neoplastic liver by free fatty acids","volume":"104","author":"Lea","year":"1967","journal-title":"Biochem J"},{"key":"10.1016\/j.plefa.2020.102142_bib0044","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000225145","article-title":"Inhibition of glycolytic enzymes of rat liver and hepatomas by free fatty acids","volume":"33","author":"Lea","year":"1976","journal-title":"Oncology"},{"key":"10.1016\/j.plefa.2020.102142_bib0045","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/srep00930","article-title":"A medium-chain fatty acid as an alternative energy source in mouse preimplantation development","volume":"2","author":"Yamada","year":"2012","journal-title":"Sci Rep"},{"key":"10.1016\/j.plefa.2020.102142_bib0046","doi-asserted-by":"crossref","DOI":"10.1093\/ajcn\/53.4.1082S","article-title":"Oncolytic effects of fatty acids in mice and rats","volume":"53","author":"Burton","year":"1991","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 4","key":"10.1016\/j.plefa.2020.102142_bib0047","first-page":"61","volume":"20","author":"Johnson","year":"2001","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.plefa.2020.102142_bib0048","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0887-2333(02)00095-4","article-title":"Ranking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysis","volume":"16","author":"Lima","year":"2002","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.plefa.2020.102142_bib0049","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clnesp.2017.11.007","article-title":"Erythrocyte membrane saturated fatty acids profile in newly diagnosed Basal Cell Carcinoma patients","volume":"23","author":"Rahrovani","year":"2018","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.plefa.2020.102142_bib0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0736-5748(96)00069-X","article-title":"Correlation of in vitro anti-proliferative potential with in vivo teratogenicity in a series of valproate analogues","volume":"15","author":"Courage-Maguire","year":"1997","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.plefa.2020.102142_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/genes9110522","article-title":"Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt\/\u03b2 Catenin Signalling Activation","volume":"9","author":"Riva","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.plefa.2020.102142_bib0052","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1080\/00207450701540062","article-title":"Medroxyprogesterone acetate induces c6 glioma chemosensitization via antidepressant-like lysosomal phospholipidosis\/myelinosis in vitro","volume":"117","author":"Altinoz","year":"2007","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.plefa.2020.102142_bib0053","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clineuro.2018.12.022","article-title":"Medroxyprogesterone effects on colony growth, autophagy and mitochondria of C6 glioma cells are augmented with tibolone and temozolomide: Cell kinetic and electron microscopical studies with a broad review of the literature","volume":"177","author":"Elmaci","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.plefa.2020.102142_bib0054","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1227\/01.NEU.0000315282.61035.48","article-title":"Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas","volume":"63","author":"McGirt","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.plefa.2020.102142_bib0055","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jocn.2011.09.031","article-title":"Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma","volume":"19","author":"Link","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.plefa.2020.102142_bib0056","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clineuro.2018.05.020","article-title":"The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis","volume":"170","author":"Lu","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.plefa.2020.102142_bib0057","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clineuro.2019.02.011","article-title":"The effects of hyperglycemia on outcomes in surgical high-grade glioma patients","volume":"179","author":"Decker","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.plefa.2020.102142_bib0058","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0026-0495(65)80013-0","article-title":"Effects of infusion of octanoate on glucose concentration in plasma and the rates of glucose production and utilization in dogs","volume":"14","author":"Sanbar","year":"1965","journal-title":"Metabolism"},{"key":"10.1016\/j.plefa.2020.102142_bib0059","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(67)90443-6","article-title":"Effects of octanoic acid on serum-levels of free fatty acids, insulin, and glucose in patients with cirrhosis and in healthy volunteers","volume":"1","author":"Linscheer","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2020.102142_bib0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0887-8994(85)90031-1","article-title":"Alterations in serum glucose and hepatic glycogen concentrations during octanoate administration in rabbits","volume":"1","author":"Trice","year":"1985","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.plefa.2020.102142_bib0061","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.154.3754.1357","article-title":"Feedback inhibition of key glycolytic enzymes in liver: action of free fatty acids","volume":"154","author":"Weber","year":"1966","journal-title":"Science"},{"key":"10.1016\/j.plefa.2020.102142_bib0062","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/abbi.1994.1110","article-title":"Importance of the modulation of glycolysis in the control of lactate metabolism by fatty acids in isolated hepatocytes from fed rats","volume":"309","author":"Morand","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.plefa.2020.102142_bib0063","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0969-8051(96)00148-5","article-title":"[1-11C]octanoate as a potential PET tracer for studying glial functions: PET evaluation in rats and cats","volume":"23","author":"Kuge","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.plefa.2020.102142_bib0064","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF03164800","article-title":"Uptake of radioactive octanoate in astrocytoma cells: basic studies for application of [11C]octanoate as a PET tracer","volume":"10","author":"Yamazaki","year":"1996","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.plefa.2020.102142_bib0065","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1248\/bpb.23.984","article-title":"[1-11C]Octanoate as a PET tracer for studying ischemic stroke: evaluation in a canine model of thromboembolic stroke with positron emission tomography","volume":"23","author":"Kuge","year":"2000","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.plefa.2020.102142_bib0066","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02990482","article-title":"Preliminary evaluation of [1-11C]octanoate as a PET tracer for studying cerebral ischemia: a PET study in rat and canine models of focal cerebral ischemia","volume":"14","author":"Kuge","year":"2000","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.plefa.2020.102142_bib0067","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0969-8051(01)00309-2","article-title":"In vitro uptake of [1-14C]Octanoate in brain slices of rats: basic studies for assessing [1-11C]Octanoate as a PET tracer of glial functions","volume":"29","author":"Kuge","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.plefa.2020.102142_bib0068","first-page":"486","article-title":"Blood D-(-)-3-hydroxybutyrate concentrations after oral administration of trioctanoin, trinonanoin, or tridecanoin to newborn rhesus monkeys (Macaca mulatta)","volume":"60","author":"Tetrick","year":"2010","journal-title":"Comp Med"},{"key":"10.1016\/j.plefa.2020.102142_bib0069","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0887-8994(85)90004-9","article-title":"Effect of octanoate injection on rat blood-brain barrier","volume":"1","author":"Trauner","year":"1985","journal-title":"Pediatr Neurol"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327820301009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327820301009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:08:45Z","timestamp":1760602125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327820301009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":68,"alternative-id":["S0952327820301009"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102142","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caprylic (Octanoic) Acid as a Potential Fatty Acid Chemotherapeutic for Glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102142"}}